Carmo, Helison Rafael P; Yoshinaga, Marcos Yukio 
; Castillo, Alejandro Rosell; Chaves Filho, Adriano de Britto ; Bonilha, Isabella; Barreto, Joaquim ; Muraro, Stéfanie Primon ; Souza, Gabriela Fabiano de ; Davanzo, Gustavo Gastão ; Perroud Junior, Mauricio Wesley ; Lukhna, Kishal ; Ntsekhe, Mpiko ; Davidson, Sean ; Velloso, Licio A; Nadruz, Wilson ; Carvalho, Luiz Sérgio F ; Jaspeado, Miguel Sáinz ; Miyamoto, Sayuri
Source: Molecular Genetics and Metabolism. Unidade: IQ
Subjects: LIPOPROTEÍNAS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARMO, Helison Rafael P et al. Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19. Molecular Genetics and Metabolism, v. 138, n. 4, p. 1-8 art. 107552, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ymgme.2023.107552. Acesso em: 11 nov. 2024.APA
Carmo, H. R. P., Yoshinaga, M. Y., Castillo, A. R., Chaves Filho, A. de B., Bonilha, I., Barreto, J., et al. (2023). Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19. Molecular Genetics and Metabolism, 138( 4), 1-8 art. 107552. doi:10.1016/j.ymgme.2023.107552NLM
Carmo HRP, Yoshinaga MY, Castillo AR, Chaves Filho A de B, Bonilha I, Barreto J, Muraro SP, Souza GF de, Davanzo GG, Perroud Junior MW, Lukhna K, Ntsekhe M, Davidson S, Velloso LA, Nadruz W, Carvalho LSF, Jaspeado MS, Miyamoto S. Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19 [Internet]. Molecular Genetics and Metabolism. 2023 ; 138( 4): 1-8 art. 107552.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ymgme.2023.107552Vancouver
Carmo HRP, Yoshinaga MY, Castillo AR, Chaves Filho A de B, Bonilha I, Barreto J, Muraro SP, Souza GF de, Davanzo GG, Perroud Junior MW, Lukhna K, Ntsekhe M, Davidson S, Velloso LA, Nadruz W, Carvalho LSF, Jaspeado MS, Miyamoto S. Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19 [Internet]. Molecular Genetics and Metabolism. 2023 ; 138( 4): 1-8 art. 107552.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ymgme.2023.107552
